Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Claytons research contributions to PT-141 development include: Principal investigator for pivotal Phase 2 dose-finding trial establishing optimal 1.75 mg dose Lead investigator for RECONNECT Phase 3 trials supporting FDA approval Development of responder analysis methodology for patient-reported outcomes in sexual dysfunction Neurobehavioral research elucidating central mechanisms of sexual desire Extensive publication record on bremelanotide efficacy, safety, and clinical applications Her work has established PT-141 as the second FDA-approved pharmacological treatment for HSDD and the first melanocortin-based therapy for sexual dysfunction, representing a significant advance in womens sexual health treatment options
Reconstitute with the listed diluent using standard aseptic laboratory technique
Who Can Benefit from PRP or GFC
The non-sticky sunscreen also contains L-Glutathione that deeply brightens skin and provides intensive moisturizer to flourish skin in one step
US$ 28.24
US$ 21.81
US$ 23.48
US$ 29.08
US$ 23.63
US$ 21.95
US$ 24.43
US$ 25.12
US$ 27.41
US$ 28.09
